Related Experiment Videos
Can fenretinide protect women against ovarian cancer?
Journal of the National Cancer Institute
|January 18, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
An autoregulatory feedback loop directs the localized expression of the Drosophila CPEB protein Orb in the developing oocyte.
Development (Cambridge, England)·2001
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer.
British journal of cancer·2001
[Prognosis and risk evaluation of postoperative coronary patients (PERISCOP). Methodology and study population characteristics].
Archives des maladies du coeur et des vaisseaux·2001
[The experience of menstruation and its disorders in 603 women using contraception in 1999].
Gynecologie, obstetrique & fertilite·2001
Effect of nitric oxide donors on the central nervous system--nitroglycerin studies in the rat.
Functional neurology·2001
Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysis.
Journal of the National Cancer Institute·2026
Effectiveness of an eHealth intervention to improve quality of life in long-term breast cancer survivors: a 9-month randomized controlled trial.
Journal of the National Cancer Institute·2026
Antidepressant and antipsychotic prescriptions among 21 605 English survivors of childhood cancer: a population-based cohort.
Journal of the National Cancer Institute·2026
Recent advancements in gynecologic cancer research: a SPORE investigators meeting report.
Journal of the National Cancer Institute·2026
Breast cancer overdiagnosis in mammography trials-separating signal from noise: a meta-analysis.
Journal of the National Cancer Institute·2026
Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.
Journal of the National Cancer Institute·2026
ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.
Molecular cancer research : MCR·2026
pH-Responsive drug delivery system for tumor therapy.
Nanoscale·2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.
Organic & biomolecular chemistry·2026
Targeting RAS for Pancreatic Cancer Interception.
Cancer discovery·2026